NCT01189422View on ClinicalTrials.gov

Subcutaneous Administration of Teplizumab in Adults With Type 1 Diabetes

PHASE1TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG

teplizumab or placebo

infusion or injection

Sponsors

Lead Sponsor

MacroGenics
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

MacroGenics

INDUSTRY